Every lot published · search any lot number before you order

Tirzepatide vs Semaglutide: What SURMOUNT-5 Found

In SURMOUNT-5, adults with obesity without diabetes were randomized to tirzepatide or semaglutide. At 72 weeks the estimated mean weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide.

Tirzepatide vs Semaglutide: What SURMOUNT-5 Found. A randomized active comparison. Tirzepatide 20.2%, 72 weeks, Semaglutide 13.7%. GLP LIFE SCIENCES ยท RESEARCH BRIEF 33 A randomized active comparison Comparisons Tirzepatide 20.2%72 weeksSemaglutide 13.7%
A randomized active comparison. Illustration for this research brief.

A randomized active comparison

The result directly compares the regimens tested in that open-label trial. It does not extend to every formulation, population or duration.

How to interpret the evidence

Retatrutide was not one of the randomized interventions. Its evidence comes from its own trials, including the registered direct comparison with tirzepatide.

Give the strongest weight to studies that randomized both treatments within a shared protocol for the clinical question you are asking.

Sources